L-(-)-Fucose
10mM in DMSO
- Product Code: 201884
CAS:
2438-80-4
| Molecular Weight: | 164.16 g./mol | Molecular Formula: | C₆H₁₂O₅ |
|---|---|---|---|
| EC Number: | 219-452-7 | MDL Number: | MFCD00135607 |
| Melting Point: | 150-153 °C(lit.) | Boiling Point: | |
| Density: | Storage Condition: | -20°C |
Product Description:
L-(-)-Fucose is widely used in biochemical and biomedical research, particularly in studies related to cell signaling and immune responses. It serves as a key building block in the synthesis of complex carbohydrates found on the surface of cells, especially in glycoproteins and glycolipids. These fucose-containing structures play critical roles in cell-cell recognition, inflammation, and pathogen attachment.
It is also applied in the development of therapeutic agents, including anti-inflammatory drugs and cancer vaccines, due to its involvement in tumor-associated carbohydrate antigens. In biotechnology, L-(-)-Fucose is used to engineer glycosylated antibodies with enhanced efficacy, as fucosylation affects antibody-dependent cellular cytotoxicity (ADCC). Additionally, it supports the production of human milk oligosaccharides in infant formula research, aiming to improve gut health and immunity in newborns.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿4,050.00 |
+
-
|
L-(-)-Fucose
L-(-)-Fucose is widely used in biochemical and biomedical research, particularly in studies related to cell signaling and immune responses. It serves as a key building block in the synthesis of complex carbohydrates found on the surface of cells, especially in glycoproteins and glycolipids. These fucose-containing structures play critical roles in cell-cell recognition, inflammation, and pathogen attachment.
It is also applied in the development of therapeutic agents, including anti-inflammatory drugs and cancer vaccines, due to its involvement in tumor-associated carbohydrate antigens. In biotechnology, L-(-)-Fucose is used to engineer glycosylated antibodies with enhanced efficacy, as fucosylation affects antibody-dependent cellular cytotoxicity (ADCC). Additionally, it supports the production of human milk oligosaccharides in infant formula research, aiming to improve gut health and immunity in newborns.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :